The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These results followed ...

Shares of Clearmind are listed for trading on Nasdaq under the symbol "CMND" and the Frankfurt Stock Exchange ... SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's ...

MINGO JUNCTION — Hills Elementary School will celebrate neurodiversity with a series of activities planned during the week of March 17-21. Through the fourth-annual event, organizers are hoping to ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette Syndrome, for the ...

Shares of Clearmind are listed for trading on Nasdaq under the symbol "CMND" and the Frankfurt ... SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and ...

Both supporters and detractors have become reduced to effigies of simplified political symbols in the public ... industry who has suffered from Tourette’s Syndrome for his entire life recently ...

Neurodiversity is the diagnostic label that includes individuals with autism, ADHD, dyslexia, dyspraxia, dysgraphia and Tourette’s Syndrome ... within the infinity symbol will be worn March ...

Both supporters and detractors have become reduced to effigies of simplified political symbols in the public space ... A friend in the industry who has suffered from Tourette’s Syndrome for his entire ...